These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2171296)
1. Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid therapy for MS relapses. Miró J; Amado JA; Pesquera C; López-Cordovilla JJ; Berciano J Acta Neurol Scand; 1990 Jun; 81(6):524-8. PubMed ID: 2171296 [TBL] [Abstract][Full Text] [Related]
2. Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test. Lević Z; Micić D; Nikolić J; Stojisavljević N; Sokić D; Janković S; Kendereski A; Mavra M J Endocrinol Invest; 1996 Jan; 19(1):30-4. PubMed ID: 8851689 [TBL] [Abstract][Full Text] [Related]
3. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Fiad TM; Kirby JM; Cunningham SK; McKenna TJ Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141 [TBL] [Abstract][Full Text] [Related]
4. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery. Courtney CH; McAllister AS; McCance DR; Hadden DR; Leslie H; Sheridan B; Atkinson AB Clin Endocrinol (Oxf); 2000 Sep; 53(3):309-12. PubMed ID: 10971447 [TBL] [Abstract][Full Text] [Related]
5. The effect of epidural methylprednisolone acetate injection on the hypothalamic-pituitary-adrenal axis. Habib G; Jabbour A; Salman J; Hakim G; Haddad H J Clin Anesth; 2013 Dec; 25(8):629-33. PubMed ID: 23988802 [TBL] [Abstract][Full Text] [Related]
7. Recovery of the hypothalamic-pituitary-adrenal axis from suppression by short-term, high-dose intravenous prednisolone therapy in patients with MS. Wenning GK; Wiethölter H; Schnauder G; Müller PH; Kanduth S; Renn W Acta Neurol Scand; 1994 Apr; 89(4):270-3. PubMed ID: 8042445 [TBL] [Abstract][Full Text] [Related]
8. Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. Schuetz P; Christ-Crain M; Schild U; Süess E; Facompre M; Baty F; Nusbaumer C; Brutsche M; Müller B BMC Pulm Med; 2008 Jan; 8():1. PubMed ID: 18221550 [TBL] [Abstract][Full Text] [Related]
9. Assessment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction: comparison of ACTH stimulation, insulin-hypoglycemia and metyrapone. Hartzband PI; Van Herle AJ; Sorger L; Cope D J Endocrinol Invest; 1988 Dec; 11(11):769-76. PubMed ID: 2852194 [TBL] [Abstract][Full Text] [Related]
10. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study. Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445 [TBL] [Abstract][Full Text] [Related]
11. Effects of metyrapone on hypothalamic-pituitary-adrenal axis and sleep in women with post-traumatic stress disorder. Otte C; Lenoci M; Metzler T; Yehuda R; Marmar CR; Neylan TC Biol Psychiatry; 2007 Apr; 61(8):952-6. PubMed ID: 17336940 [TBL] [Abstract][Full Text] [Related]
12. Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy. Ford LR; Willi SM; Hollis BW; Wright NM J Pediatr; 1997 Nov; 131(5):722-6. PubMed ID: 9403653 [TBL] [Abstract][Full Text] [Related]
13. Overnight suppression of HPA axis after mineraolocorticoid receptor stimulation: A sleep endocrine study. Demiralay C; Agorastos A; Jahn H; Kellner M; Yassouridis A; Wiedemann K Psychiatry Res; 2015 May; 227(1):65-70. PubMed ID: 25799272 [TBL] [Abstract][Full Text] [Related]
14. Hypothalamic-pituitary-adrenal (HPA) function in adrenocortical steroid treated minimal change nephrotic syndrome. Moel DI; Kwun YA; Teitcher J Clin Nephrol; 1980 Jul; 14(1):36-41. PubMed ID: 6250751 [TBL] [Abstract][Full Text] [Related]
15. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Otte C; Jahn H; Yassouridis A; Arlt J; Stober N; Maass P; Wiedemann K; Kellner M Life Sci; 2003 Aug; 73(14):1835-45. PubMed ID: 12888122 [TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-pituitary-adrenal axis interaction with prostaglandins. Thorén M; Stenfors C; Apéria B; Mathé AA Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):319-26. PubMed ID: 2359842 [TBL] [Abstract][Full Text] [Related]
17. The effect of local injection of methylprednisolone acetate on the hypothalamic-pituitary-adrenal axis among patients with greater trochanteric pain syndrome. Habib G; Elias S; Abu-Elhaija M; Sakas F; Khazin F; Artul S; Jabbour A; Jabaly-Habib H Clin Rheumatol; 2017 Apr; 36(4):959-963. PubMed ID: 28013434 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the three hour metyrapone test in adults. Best JD; Alford FP; Donald RA Clin Endocrinol (Oxf); 1980 Jul; 13(1):69-76. PubMed ID: 6254698 [TBL] [Abstract][Full Text] [Related]
19. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339 [TBL] [Abstract][Full Text] [Related]